{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:18Z","timestamp":1786118958118,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/inf.0b013e3181710976","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T04:02:28Z","timestamp":1219896148000},"page":"771-775","source":"Crossref","is-referenced-by-count":17,"title":["Serious Neurologic Sequelae in Cases of Meningitis Arising From Infection by Conjugate Vaccine-Related and Nonvaccine-Related Serogroups of Streptococcus pneumoniae"],"prefix":"10.1097","volume":"27","author":[{"given":"Christiana R.","family":"Rajasingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bema K.","family":"Bonsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer I.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Barson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"RR-9","key":"R1-2-20210202","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"R3-2-20210202","first-page":"688","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"143","author":"Black","year":"2003","journal-title":"J Pediatr"},{"issue":"3","key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422653","article-title":"Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine.","volume":"39","author":"Talbot","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10096-005-1365-z","article-title":"Incidence and outcome of pneumococcal meningitis in northern England.","volume":"24","author":"Weightman","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1097\/01.CCM.0000240235.31535.AF","article-title":"Outcomes following pneumococcal meningitis: room for improvement remains expansive.","volume":"34","author":"Fisk","year":"2006","journal-title":"Crit Care Med"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.inf.0000207484.52850.38","article-title":"Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.","volume":"25","author":"Gonzalez","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R11-2-20210202","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2013United States, 1998\u20132003.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.inf.0000148891.32134.36","article-title":"Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.","volume":"24","author":"Hsu","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-4-21","article-title":"Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.","volume":"4","author":"Martens","year":"2004","journal-title":"BMC Infect Dis"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes.","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998: Opportunities for prevention in the conjugate vaccine era.","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1086\/318700","article-title":"Fever interval before diagnosis, prior antibiotic treatment, and clinical outcome for young children with bacterial meningitis.","volume":"32","author":"Bonsu","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children.","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae.","volume":"189","author":"Sandgren","year":"2004","journal-title":"J Infect Dis"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1542\/peds.108.2.e23","article-title":"Serotype prevalence of occult pneumococcal bacteremia.","volume":"108","author":"Alpern","year":"2001","journal-title":"Pediatrics"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children.","volume":"357","author":"Hausdorff","year":"2001","journal-title":"Lancet"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978\u20131997.","volume":"107","author":"Mufson","year":"1999","journal-title":"Am J Med"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1378\/chest.109.1.173","article-title":"Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Pneumococcal Bacteremia Study Group.","volume":"109","author":"Mirzanejad","year":"1996","journal-title":"Chest"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/315761","article-title":"Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries.","volume":"182","author":"Henriques","year":"2000","journal-title":"J Infect Dis"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1469-0691.2003.00603.x","article-title":"A five-year survey of pneumococcal peritonitis in two Danish counties\u2013incidence, diagnosis and clinical entities.","volume":"9","author":"Nielsen","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200809000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:02:34Z","timestamp":1786035754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200809000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181710976","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}